Matches in Wikidata for { <http://www.wikidata.org/entity/Q92667885> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- Q92667885 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q92667885 description "im August 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92667885 description "scientific article published on 15 August 2019" @default.
- Q92667885 description "wetenschappelijk artikel" @default.
- Q92667885 description "наукова стаття, опублікована 15 серпня 2019" @default.
- Q92667885 name "Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer" @default.
- Q92667885 name "Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer" @default.
- Q92667885 type Item @default.
- Q92667885 label "Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer" @default.
- Q92667885 label "Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer" @default.
- Q92667885 prefLabel "Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer" @default.
- Q92667885 prefLabel "Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer" @default.
- Q92667885 P1433 Q92667885-B6FD4EBD-7E3B-4CD7-9803-6529B45E315D @default.
- Q92667885 P1476 Q92667885-8C331E3D-F617-4564-9214-137BF054B338 @default.
- Q92667885 P2093 Q92667885-05323AE2-1F97-4F60-AC26-8B2DD4C94861 @default.
- Q92667885 P2093 Q92667885-0891ABCC-D04E-4B41-9135-5A8C4624021A @default.
- Q92667885 P2093 Q92667885-24A2F4DC-7BFA-4213-B1BD-D14238212B45 @default.
- Q92667885 P2093 Q92667885-3CCA1FB8-4B0C-4078-BBDB-76FD6789156A @default.
- Q92667885 P2093 Q92667885-3D45A63B-3791-4622-B1DA-EDECB230B9F5 @default.
- Q92667885 P2093 Q92667885-3E403EC8-FA08-4C75-9254-EFBCB273955B @default.
- Q92667885 P2093 Q92667885-5AE9BF9D-1E95-46A7-BB45-3B0317F8EA1A @default.
- Q92667885 P2093 Q92667885-6049147C-84D2-4449-BFAE-97D967961981 @default.
- Q92667885 P2093 Q92667885-76530B2C-3486-4510-AFB9-08AEF35EE033 @default.
- Q92667885 P2093 Q92667885-77BF1443-3D32-4365-BA68-F5AF02B7A4AD @default.
- Q92667885 P2093 Q92667885-784E7C71-19D3-45BB-844D-159082445386 @default.
- Q92667885 P2093 Q92667885-8C463676-8CE7-4BED-B1C2-979B6A78204E @default.
- Q92667885 P2093 Q92667885-8E5D9E0A-8FCE-4176-9880-A1B9C34538F7 @default.
- Q92667885 P2093 Q92667885-9835F103-9F0E-4642-985F-E638D4357641 @default.
- Q92667885 P2093 Q92667885-A0D7C16A-9B6F-411C-8BCD-A6350401A3D5 @default.
- Q92667885 P2093 Q92667885-DC6E3D95-30D5-4DFD-BC06-D4C7DDF71003 @default.
- Q92667885 P2093 Q92667885-E1585AB6-42C5-4DA8-905E-81E4B76953A2 @default.
- Q92667885 P2093 Q92667885-EE6822D4-F472-4CE1-A0FF-04922576BBD2 @default.
- Q92667885 P2093 Q92667885-F762AC3F-E699-4E52-9154-3464C24B1732 @default.
- Q92667885 P2093 Q92667885-FA20AD2B-A074-47FE-A593-F81FF004E844 @default.
- Q92667885 P304 Q92667885-E06572EA-9EED-4F85-9686-2A2D28889FDA @default.
- Q92667885 P31 Q92667885-E793DA45-1FF7-46D2-A8B3-1A16E942DDCE @default.
- Q92667885 P356 Q92667885-3B02E74A-1DA8-4671-A0CE-EA971F356E8C @default.
- Q92667885 P433 Q92667885-A7FA64AD-2E3D-499D-B2F1-A656137ACE0A @default.
- Q92667885 P478 Q92667885-A08F26C0-B899-4683-A1C7-8E24A8DAA185 @default.
- Q92667885 P50 Q92667885-5F0E3154-7858-472B-B399-CAE6641A7503 @default.
- Q92667885 P50 Q92667885-A29E8C66-F32B-4880-A2A5-31C35B242FBF @default.
- Q92667885 P50 Q92667885-D5F76B2D-E127-496A-A021-601560E57400 @default.
- Q92667885 P577 Q92667885-EB812CF5-2FBF-4059-B7F8-0305C8586041 @default.
- Q92667885 P698 Q92667885-DF56722B-D5DD-418D-9F20-E1BDB6C0588D @default.
- Q92667885 P921 Q92667885-0E567ABF-BD71-4625-ABC1-59FE9142CABE @default.
- Q92667885 P921 Q92667885-64421ADF-2EF8-4ECC-BA3F-BA88342CE2A7 @default.
- Q92667885 P356 IJGC-2019-000370 @default.
- Q92667885 P698 31420414 @default.
- Q92667885 P1433 Q15749181 @default.
- Q92667885 P1476 "Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer" @default.
- Q92667885 P2093 "Andreas du Bois" @default.
- Q92667885 P2093 "Andrés Redondo" @default.
- Q92667885 P2093 "Antonio González Martin" @default.
- Q92667885 P2093 "Beatriz Pardo" @default.
- Q92667885 P2093 "Christian Kurzeder" @default.
- Q92667885 P2093 "Domenica Lorusso" @default.
- Q92667885 P2093 "Dominique Berton-Rigaud" @default.
- Q92667885 P2093 "Elfriede Greimel" @default.
- Q92667885 P2093 "Eva-Maria Grischke" @default.
- Q92667885 P2093 "Frédéric Selle" @default.
- Q92667885 P2093 "Hans-Joachim Lück" @default.
- Q92667885 P2093 "Jeronimo Martinez-Garcia" @default.
- Q92667885 P2093 "Joern Rau" @default.
- Q92667885 P2093 "Judith R Kroep" @default.
- Q92667885 P2093 "Lydie Bastière-Truchot" @default.
- Q92667885 P2093 "Mansoor R Mirza" @default.
- Q92667885 P2093 "Nicoletta Colombo" @default.
- Q92667885 P2093 "PENELOPE trial investigators" @default.
- Q92667885 P2093 "Petronella Ottevanger" @default.
- Q92667885 P2093 "Regina Berger" @default.
- Q92667885 P304 "1141-1147" @default.
- Q92667885 P31 Q13442814 @default.
- Q92667885 P356 "10.1136/IJGC-2019-000370" @default.
- Q92667885 P433 "7" @default.
- Q92667885 P478 "29" @default.
- Q92667885 P50 Q124151001 @default.
- Q92667885 P50 Q89808263 @default.
- Q92667885 P50 Q89960045 @default.
- Q92667885 P577 "2019-08-15T00:00:00Z" @default.
- Q92667885 P698 "31420414" @default.
- Q92667885 P921 Q172341 @default.
- Q92667885 P921 Q42824827 @default.